Search
for

    Learn

    5 / 801 results

    Research

    5 / 1000+ results
      Telogen Effluvium: A Review

      research Telogen effluvium: a review

      2 citations , January 2019 in “International Journal of Medicine in Developing Countries”
      Telogen Effluvium is a common hair loss condition, particularly in women, with no specific FDA-approved treatment, and recovery can take up to 18 months.

      research Polycystic Ovary Syndrome

      2 citations , February 2005 in “Postgraduate obstetrics & gynecology”
      Certain medications can help treat PCOS symptoms, but they aren't FDA-approved for this use.
      Medicine Update

      research Medicine Update

      February 2024 in “IJCP”
      The CDC reports 23 measles cases in unvaccinated US kids, new treatments for eosinophilic esophagitis and osteopenia are approved, poor sleep may cause migraines, atopic dermatitis could lead to asthma, migraines might increase Crohn's disease risk, cancer may raise heart disease risk, gout is linked to prostate issues, Cabo Verde is malaria-free, social factors and vitamin D affect dementia risk, smoking increases hair loss risk, certain drugs might lower thyroid disease risk in arthritis, noma is a neglected disease, and meal timing could impact heart health.

    Community Join

    5 / 1000+ results

      community Why are more people not using RU58841

      in Product  14 upvotes 1 year ago
      People are not using RU58841 for hair loss because it's not FDA approved, lacks long-term safety data, and is difficult to obtain and verify. They prefer FDA-approved treatments like minoxidil, finasteride, ketoconazole shampoo, and microneedling.

      community Why is everyone not directly advised Dutasteride?

      in Finasteride/Dutasteride  169 upvotes 1 year ago
      Dutasteride is less commonly prescribed for hair loss because it is not FDA-approved for this purpose, unlike finasteride, which is more accessible and preferred due to fewer side effects. Dutasteride may be more effective in reducing DHT but has a longer half-life and potentially more significant side effects.

      community So we’re just ok with taking a research chemical now?

      in Treatment  182 upvotes 5 years ago
      The conversation discusses the use of RU58841, a non-FDA approved research chemical for hair loss, with mixed opinions on its safety and effectiveness. Some users are willing to try it as a last resort after other treatments like Minoxidil and Finasteride failed, while others express concerns about potential long-term side effects and lack of official research.